Integration of Evolutionary Analysis With RFdiffusion for De Novo Design of Aggregation‐Resistant Frataxin
- 21 January 2026
- journal article
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 94 (6) , 1225-1244
Abstract
Friedreich's ataxia (FRDA) is a neurodegenerative disorder caused by frataxin (FXN) deficiency, where protein replacement therapy is hampered by the inherent instability and aggregation propensity of wild‐type (WT) FXN. The structural flexibility of Loop‐1 (residues 115–123), a critical region within the acidic ridge, represents a key determinant of protein stability. This study introduces a computational pipeline integrating evolutionary conservation analysis (ConSurf) with diffusion‐based de novo design (RFdiffusion) to redesign both the backbone and sequence of Loop‐1. Through systematic filtration of 1000 ProteinMPNN‐generated variants using aggregation propensity screening (AGGRESCAN) and 450 ns of molecular dynamics (MD) simulations, four lead candidates were identified. Design_188 (EERVGGREI) demonstrated optimal performance with 2.3‐fold improvement in aggregation resistance (Na4vSS: −53.8 vs. −23.5 for WT), superior structural stability (RMSD: 0.486 nm), reduced conformational diversity (62.3% dominant cluster occupancy), and 93% retention of ISCU binding capacity (ΔΔG: +6.4 kcal/mol). Experimental validation through 15 N NMR relaxation analysis confirmed computational predictions, with Design_188 exhibiting uniform backbone rigidification (S 2 = 0.81–0.95) and strong MD‐NMR correlation (Pearson r = 0.675, p = 0.003). SEC‐MALS analysis demonstrated near‐complete monomeric behavior (> 98% monomer content) compared to WT's heterogeneous oligomerization (68% monomer, 32% oligomers), directly confirming the predicted anti‐aggregation properties. K‐means clustering analysis revealed an inverse relationship between conformational heterogeneity and stability, while correlation analysis identified a fundamental trade‐off between aggregation resistance and structural stability ( r = −0.82, p < 0.01). This work establishes a generalizable framework for therapeutic protein engineering where backbone redesign enables conformational ensemble modulation beyond the limitations of sequence optimization alone.Keywords
Funding Information
- Friedreich's Ataxia Research Alliance
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Türkiye Sağlık Enstitüleri Başkanlığı (4733406.03.2025‐A3‐01)
This publication has 50 references indexed in Scilit:
- Computational Peptide Design for Diverse Structures and Functions2025
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Protein folding in vitro and in the cell: From a solitary journey to a team effortBiophysical Chemistry, 2022
- Relationship between activity and stability: Design and characterization of stable variants of human frataxinArchives of Biochemistry and Biophysics, 2020
- Exploring iron-binding to human frataxin and to selected Friedreich ataxia mutants by means of NMR and EPR spectroscopiesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2019
- Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster BiogenesisCell, 2019
- Insights on the conformational dynamics of human frataxin through modifications of loop-1Archives of Biochemistry and Biophysics, 2017
- Structural characterization of metal binding to a cold-adapted frataxinJBIC Journal of Biological Inorganic Chemistry, 2015
- Protein aggregation and its impact on product qualityCurrent Opinion in Biotechnology, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012